{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:54:51Z","timestamp":1794074091774,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["YSS\/2015\/001321"],"award-info":[{"award-number":["YSS\/2015\/001321"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2014-1182"],"award-info":[{"award-number":["2014-1182"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Early diagnosis is important for the timely treatment of gallbladder carcinoma (GBC) patients and may lead to increased survival outcomes. Here, we have applied serological proteome analysis (SERPA), an immunoproteomics approach, for the\u00a0detection of \u2018tumor-associated antigens (TAAs) that elicit humoral response\u2019 in early stage GBC patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Total protein from pooled tumor tissue of GBC patients (<jats:italic>n<\/jats:italic>\u2009=\u20097) was resolved by two-dimensional gel electrophoresis (2-DE) followed by immunoblotting using pooled blood plasma from healthy volunteers (<jats:italic>n<\/jats:italic>\u2009=\u200911) or gallstone disease (GSD) cases (<jats:italic>n<\/jats:italic>\u2009=\u200911) or early stage GBC (Stage I and II) (<jats:italic>n<\/jats:italic>\u2009=\u20095) or GBC stage IIIA (<jats:italic>n<\/jats:italic>\u2009=\u20099). 2-D gel and immunoblot images were acquired and analyzed using PDQuest software to identify immunoreactive spots in GBC cases in comparison to controls. Proteins from immunoreactive spots were identified by liquid chromatography- tandem mass spectrometric analysis (LC-MS\/MS). Autoantibody levels for two of the functionally relevant proteins were investigated in individual plasma samples (52 cases and 89 controls) by dot blot assay using recombinant proteins.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Image analysis using PDQuest software identified 25 protein spots with significantly high or specific immunoreactivity in GBC cases. Mass spectrometric analysis of 8 corresponding protein spots showing intense immunoreactivity (based on densitometric analysis) in early stage GBC or GBC stage IIIA cases led to the identification of 27 proteins. Some of the identified proteins include ANXA1, HSPD1, CA1, CA2, ALDOA and CTSD. Among the two proteins, namely ANXA1 and HSPD1 verified using a cohort of samples, significantly elevated autoantibody levels against ANXA1 were observed in early stage GBC cases in comparison to healthy volunteers or GSD cases (unpaired t-test, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Receiver operating characteristic (ROC) curve analysis for ANXA1 showed an Area under the Curve (AUC) of 0.69, with 41.7% sensitivity against a specificity of 89.9% for early stage GBC. IHC analysis for ANXA1 protein showed \u2018high\u2019 expression levels in 72% of GBC cases whereas all the controls showed \u2018low\u2019 expression levels.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The study suggests that the ANXA1 autoantibody levels against ANXA1 may be potentially employed for early stage detection of GBC patients. Other proteins could also be explored and verified in a large cohort of clinical samples.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07676-6","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:04:14Z","timestamp":1606809854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Javed","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Sakhuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Varma","family":"Polisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Sirdeshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-6157","authenticated-orcid":false,"given":"Poonam","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"7676_CR1","first-page":"563","volume":"10","author":"N Mahdavifar","year":"2017","unstructured":"Mahdavifar N, Pakzad R, Ghoncheh M, Gandomani HS, Salehiniya H. Epidemiology, incidence, and mortality of gallbladder cancer and its relation with development in the world. Ann Trop Med Public Health. 2017;10:563\u201370.","journal-title":"Ann Trop Med Public Health"},{"issue":"4","key":"7676_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4103\/ijc.IJC_393_17","volume":"54","author":"RK Malhotra","year":"2017","unstructured":"Malhotra RK, Manoharan N, Shukla NK, Rath GK. Gallbladder cancer incidence in Delhi urban: a 25-year trend analysis. Indian J Cancer. 2017;54(4):673\u20137.","journal-title":"Indian J Cancer"},{"key":"7676_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchi C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"7676_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168\u201381.","journal-title":"Oncologist."},{"issue":"4","key":"7676_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12664-017-0775-z","volume":"36","author":"SH Shah","year":"2017","unstructured":"Shah SH, Gupta N, Gupta G, Mehta A, Singh S. Lymph node micrometastasis in gallbladder cancer. Indian J Gastroenterol. 2017;36(4):268\u201374.","journal-title":"Indian J Gastroenterol"},{"key":"7676_CR6","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1111\/j.1742-4658.2009.07396.x","volume":"276","author":"HT Tan","year":"2009","unstructured":"Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 2009;276:6880\u2013904.","journal-title":"FEBS J"},{"key":"7676_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1074\/mcp.R600010-MCP200","volume":"5","author":"CA Casiano","year":"2006","unstructured":"Casiano CA, Mediavilla-Varela M, Tan EM. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics. 2006;5:1745\u201359.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"7676_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.trecan.2017.02.003","volume":"3","author":"IK Macdonald","year":"2017","unstructured":"Macdonald IK, Parsy-Kowalska CB, Chapman CJ. Autoantibodies: opportunities for early Cancer detection. Trends Cancer. 2017;3(3):198\u2013213.","journal-title":"Trends Cancer"},{"issue":"4","key":"7676_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1586\/epr.09.56","volume":"6","author":"C Desmetz","year":"2009","unstructured":"Desmetz C, Maudelonde T, Mang\u00e9 A, Solassol J. Identifying autoantibody signatures in cancer: a promising challenge. Expert Rev Proteomics. 2009;6(4):377\u201386.","journal-title":"Expert Rev Proteomics"},{"issue":"12","key":"7676_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/prca.200700206","volume":"1","author":"S Shukla","year":"2007","unstructured":"Shukla S, Govekar RB, Sirdeshmukh R, Sundaram CS, D'Cruz AK, Pathak KA, et al. Tumor antigens eliciting autoantibody response in cancer of gingivo-buccal complex. Proteomics Clin Appl. 2007;1(12):1592\u2013604.","journal-title":"Proteomics Clin Appl"},{"issue":"9","key":"7676_CR11","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1021\/pr800273h","volume":"7","author":"KS Looi","year":"2008","unstructured":"Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res. 2008;7(9):4004\u201312.","journal-title":"J Proteome Res"},{"issue":"5","key":"7676_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/prca.201500138","volume":"10","author":"P Gupta","year":"2016","unstructured":"Gupta P, Suman S, Mishra M, Mishra S, Srivastava N, Kumar V, et al. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients. Proteomics Clin Appl. 2016;10(5):564\u201373.","journal-title":"Proteomics Clin Appl"},{"key":"7676_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-015-0751-2","volume":"14","author":"MZ Mustafa","year":"2016","unstructured":"Mustafa MZ, Nguyen VH, Le Naour F, De Martin E, Beleoken E, Guettier C, et al. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma. J Transl Med. 2016;14:17.","journal-title":"J Transl Med"},{"issue":"2","key":"7676_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7676_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/elps.1150090111","volume":"9","author":"A G\u00f6rg","year":"1988","unstructured":"G\u00f6rg A, Postel W, G\u00fcnther S, Friedrich C. Horizontal twodimensional electrophoresis with immobilized pH gradients using PhastSystem. Electrophoresis. 1988;9(1):57\u20139.","journal-title":"Electrophoresis."},{"key":"7676_CR16","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, et al. Human protein reference database--2009 update. Nucleic Acids Res. 2009;37:D767\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"7676_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2016.01.017","volume":"15","author":"P Zaenker","year":"2016","unstructured":"Zaenker P, Gray ES, Ziman MR. Autoantibody production in Cancer--the Humoral immune response toward autologous antigens in Cancer patients. Autoimmun Rev. 2016;15(5):477\u201383.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"7676_CR18","first-page":"595","volume":"32","author":"LP Yang","year":"2010","unstructured":"Yang LP, Yang ZL, Tan XG, Miao XY. Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder. ZhonghuaZhong Liu ZaZhi. 2010;32(8):595\u20139.","journal-title":"ZhonghuaZhong Liu ZaZhi"},{"issue":"16","key":"7676_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3748\/wjg.v19.i16.2456","volume":"19","author":"N Hongsrichan","year":"2013","unstructured":"Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, et al. Annexin A1: a new immunohistological marker of cholangiocarcinoma. World J Gastroenterol. 2013;19(16):2456\u201365.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"7676_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/path.2400","volume":"216","author":"S Mussunoor","year":"2008","unstructured":"Mussunoor S, Murray GI. The role of annexins in tumour development and progression. J Pathol. 2008;216(2):131\u201340.","journal-title":"J Pathol"},{"issue":"4","key":"7676_CR21","doi-asserted-by":"publisher","first-page":"pii: E1045","DOI":"10.3390\/ijms19041045","volume":"19","author":"MH Sheikh","year":"2018","unstructured":"Sheikh MH, Solito E, et al. Int J Mol Sci. 2018;19(4):pii: E1045.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7676_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/annonc\/mdq361","volume":"22","author":"P Boyle","year":"2011","unstructured":"Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol. 2011;22(2):383\u20139.","journal-title":"Ann Oncol"},{"issue":"8","key":"7676_CR23","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/annonc\/mdp606","volume":"21","author":"A Murray","year":"2010","unstructured":"Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, et al. Technical validation of an autoantibody test for lung cancer. Ann Oncol. 2010;21(8):1687\u201393.","journal-title":"Ann Oncol"},{"issue":"5","key":"7676_CR24","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1007\/s13277-014-1643-4","volume":"35","author":"W Wang","year":"2014","unstructured":"Wang W, Guan S, Sun S, Jin Y, Lee KH, Chen Y, et al. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer. Tumour Biol. 2014;35(5):4901\u20135.","journal-title":"Tumour Biol"},{"issue":"2","key":"7676_CR25","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s13277-014-2751-x","volume":"36","author":"Y Huang","year":"2015","unstructured":"Huang Y, Zhang C, Chen C, Sun S, Zheng H, Wan S, et al. Investigation of circulating antibodies to ANXA1 in breast cancer. Tumour Biol. 2015;36(2):1233\u20136.","journal-title":"Tumour Biol"},{"key":"7676_CR26","first-page":"87","volume":"10","author":"Y Shirai","year":"2012","unstructured":"Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J SurgOncol. 2012;10:87.","journal-title":"World J SurgOncol"},{"issue":"7","key":"7676_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jjco\/hyq028","volume":"40","author":"NY Shih","year":"2010","unstructured":"Shih NY, Lai HL, Chang GC, Lin HC, Wu YC, Liu JM, et al. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Jpn J Clin Oncol. 2010;40(7):663\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"7676_CR28","first-page":"2284","volume":"10","author":"L Ye","year":"2017","unstructured":"Ye L, Wang Y, Liu T, Liu B, Liu F, Liu B. Circulating antibody to ANXA1 may be a potential biomarker for early diagnosis of esophageal cancer. Int J Clin Exp Pathol. 2017;10(2):2284\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"7676_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ebiom.2015.03.010","volume":"2","author":"Y Hong","year":"2015","unstructured":"Hong Y, Long J, Li H, Chen S, Liu Q, Zhang B, et al. An analysis of Immunoreactive signatures in early stage hepatocellular carcinoma. EBioMedicine. 2015;2(5):438\u201346.","journal-title":"EBioMedicine."},{"issue":"1","key":"7676_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bios.2012.08.019","volume":"40","author":"Z Yang","year":"2013","unstructured":"Yang Z, Chevolot Y, G\u00e9hin T, Solassol J, Mange A, Souteyrand E, et al. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera. BiosensBioelectron. 2013;40(1):385\u201392.","journal-title":"BiosensBioelectron."},{"issue":"6","key":"7676_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/sji.12430","volume":"83","author":"J Xia","year":"2016","unstructured":"Xia J, Shi J, Wang P, Song C, Wang K, Zhang J, et al. Tumour-associated autoantibodies as diagnostic biomarkers for breast Cancer: a systematic review and meta-analysis. Scand J Immunol. 2016;83(6):393\u2013408.","journal-title":"Scand J Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-07676-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:11:54Z","timestamp":1606810314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07676-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7676"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07676-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clinical samples from patients visiting GIPMER, Delhi, were collected for the study after approval from the Institutional Human Ethics Committee [F.1\/IEC\/MAMC\/(52\/1\/2016\/No. 36) and NIP-IEC\/21\u201312\/05]. All patients provided informed consent to participate in the study and written informed consent was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1175"}}